Patents Assigned to National Cancer Center
-
Publication number: 20240018224Abstract: An object of the present invention is to provide: an anti-GPC3 antibody that recognizes an epitope different from that for existing antibodies (e.g., GC33 and GC199) and can specifically bind, even in the form of single chain antibody, to GPC3 localized on a cell membrane; CAR comprising the anti-GPC3 single chain antibody; an immunocompetent cell expressing the CAR; a gene of the anti-GPC3 antibody or a gene of the CAR; a vector comprising the anti-GPC3 antibody gene or the CAR gene; a host cell in which the vector has been introduced; a method for specifically detecting GPC3; and a kit for specifically detecting GPC3. An antibody comprising particular heavy chain CDR1 to CDR3 and particular light chain CDR1 to CDR3 defined in claim 1, and specifically binding to a human-derived GPC3 polypeptide specifically binds to GPC3 localized on a cell membrane. CAR-immunocompetent cells prepared on the basis of CAR comprising such single chain antibody are useful for cancer immunotherapy.Type: ApplicationFiled: June 15, 2023Publication date: January 18, 2024Applicants: Yamaguchi University, National Cancer Center, Noile-Immune Biotech, Inc.Inventors: Koji TAMADA, Yukimi SAKODA, Tetsuya NAKATSURA, Keigo SAITO
-
Publication number: 20240011104Abstract: This invention provides a kit or a device for the detection of pancreatic cancer, comprising a nucleic acid(s) capable of specifically binding to a miRNA(s) in a sample from a subject, and a method for detecting pancreatic cancer, comprising measuring the miRNA(s) in vitro.Type: ApplicationFiled: September 7, 2023Publication date: January 11, 2024Applicants: TORAY INDUSTRIES, INC., NATIONAL CANCER CENTERInventors: Junpei KAWAUCHI, Hitoshi NOBUMASA, Satoko KOZONO, Satoshi KONDOU, Hiroko SUDO, Atsushi OCHIAI, Motohiro KOJIMA
-
Patent number: 11869193Abstract: A method includes: inputting an image of a target to each of a first model for estimating a region of an annular face of the target, a second model for estimating a region in an outer circumference of the annular face and a third model for estimating a region in an inner circumference of the annular face, and outputting a region image, as an estimated region of the annular face, the region image being obtained by synthesizing first, second, and third elements. The first element is a region outputted as a result of the first model for calculating a sum set in the synthesizing, the second element is a region outputted as a result of the second model for calculating a sum set in the synthesizing, and the third element is a region outputted as a result of the third model for calculating a difference set in the synthesizing.Type: GrantFiled: January 8, 2021Date of Patent: January 9, 2024Assignees: Fujitsu Limited, RIKEN, NATIONAL CANCER CENTERInventors: Akira Sakai, Masaaki Komatsu, Kanto Shozu
-
Patent number: 11859256Abstract: Disclosed is a kit or a device for the detection of stomach cancer and a method for detecting stomach cancer, and provides a kit or a device for the detection of stomach cancer, including a nucleic acid(s) capable of specifically binding to a miRNA(s) in a sample from a subject, and a method for detecting stomach cancer, including measuring the miRNA(s) in vitro.Type: GrantFiled: September 20, 2022Date of Patent: January 2, 2024Assignees: TORAY INDUSTRIES, LTD., NATIONAL CANCER CENTERInventors: Satoko Kozono, Hitoshi Nobumasa, Satoshi Kondou, Hiroko Sudo, Junpei Kawauchi, Atsushi Ochiai, Motohiro Kojima
-
Patent number: 11859255Abstract: It is intended to provide a kit or a device for the detection of breast cancer and a method for detecting breast cancer. The present invention provides a kit or a device for the detection of breast cancer, comprising nucleic acid(s) capable of specifically binding to a miRNA in a sample of a subject, and a method for detecting breast cancer, comprising measuring the miRNA in vitro.Type: GrantFiled: September 14, 2022Date of Patent: January 2, 2024Assignees: TORAY INDUSTRIES, INC., NATIONAL CANCER CENTERInventors: Satoshi Kondou, Hitoshi Nobumasa, Satoko Kozono, Hiroko Sudo, Junpei Kawauchi, Takahiro Ochiya, Nobuyoshi Kosaka, Makiko Ono, Kenji Tamura
-
Publication number: 20230419517Abstract: A display processing unit causes a display device to display an endoscopic image of a living tissue in a somatic cavity captured by an endoscope. An operation reception unit receives a user operation that is performed so as to set an area of interest in the endoscopic image. An area-of-interest setting unit sets the area of interest in the endoscopic image based on the user operation. A three-dimensional information acquisition unit acquires three-dimensional shape information of the living tissue captured by the endoscope. A virtual surface derivation unit derives three-dimensional shape information of a virtual surface in the area of interest from three-dimensional shape information of an area different from the area of interest. A size information identification unit identifies information concerning a size of the virtual surface from the three-dimensional shape information of the virtual surface.Type: ApplicationFiled: September 11, 2023Publication date: December 28, 2023Applicants: OLYMPUS CORPORATION, NATIONAL CANCER CENTERInventors: Tatsuya NAKAMURA, Daichi WATANABE, Kazunari HANANO, Keigo MATSUO, Taku SAKAMOTO, Ichiro ODA
-
Publication number: 20230390344Abstract: A method for enhancing immunity, including administering a composition containing a Prevotella stercorea strain or a culture solution thereof to a subject in need thereof. A method for increasing an anticancer effect, including administering a composition containing a Prevotella stercorea strain or a culture solution thereof to a subject in need thereof. A method for treating cancer, including administering a composition containing a Prevotella stercorea strain or a culture solution thereof, and an immune checkpoint inhibitor to a subject in need thereof.Type: ApplicationFiled: October 27, 2021Publication date: December 7, 2023Applicants: THE ASAN FOUNDATION, UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION, NATIONAL CANCER CENTERInventor: Sook Ryun PARK
-
Patent number: 11827941Abstract: It is intended to provide a kit or device for the detection of liver cancer and a method for detecting liver cancer. The present invention relates to a kit or device for the detection of liver cancer, comprising a nucleic acid capable of specifically binding to miRNA in a sample of a subject, and a method for detecting liver cancer, comprising measuring the miRNA in vitro.Type: GrantFiled: October 21, 2022Date of Patent: November 28, 2023Assignees: TORAY INDUSTRIES, INC., NATIONAL CANCER CENTERInventors: Satoshi Kondou, Hitoshi Nobumasa, Satoko Kozono, Hiroko Sudo, Junpei Kawauchi, Atsushi Ochiai, Motohiro Kojima
-
Publication number: 20230371921Abstract: The present invention relates to a method for analyzing ultrasound data obtained by passing through multiple layers, comprising the steps of: reducing noise in the ultrasound data; identifying an interface between layers by identifying the peak of the ultrasound data after removal of the noise; and differentiating each layer by identifying an attenuation coefficient of the ultrasound data after removal of the noise.Type: ApplicationFiled: October 19, 2021Publication date: November 23, 2023Applicant: NATIONAL CANCER CENTERInventors: Dae Woo PARK, Dong Chan PARK
-
Patent number: 11819710Abstract: The present invention relates to a method, a device, and a program for calculating a brachytherapy plan, and a brachytherapy apparatus. The method comprises: a step in which a computer obtains the number of radiation irradiation spots on the basis of radiation irradiation information (a radiation irradiation spot number obtaining step (S200)); a step in which the computer obtains target area information from a body model of a patient generated on the basis of medical image data of the patient (a target area information obtaining step (S400)); and a therapy plan calculating step (S600) in which the computer calculates, on the basis of the radiation irradiation information and the target area information, the radiation irradiation spots to which radiation is irradiated and the time length of irradiation to each radiation irradiation spot.Type: GrantFiled: December 3, 2020Date of Patent: November 21, 2023Assignees: THE ASAN FOUNDATION, UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION, NATIONAL CANCER CENTER, THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY, KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCESInventors: Ho Jin Kim, Jung Won Kwak, Byung Chul Cho, Sang Wook Lee, Chi Young Jeong, Young Kyung Lim, Ui Jung Hwang, Sang Hyoun Choi
-
Publication number: 20230365988Abstract: The present invention relates to a mouse model for bio-imaging of inflammation, a preparation method therefor and a use thereof. Particularly, by using the mouse model, which is made by crossing a mouse model with a mouse expressing Cre recombinase specifically in certain tissues and cells, certain tissue- and cell-specific inflammatory signals desired by a researcher can be evaluated in vitro and the progress of inflammatory changes over time without the autopsy of living animals can be identified, and thus the present invention can be used throughout the field of life science research including experimental animal science, molecular biology and the like, and can also be used as a model for efficacy evaluation of anti-inflammatory candidates in the industrial area such as new drug or health functional food development and the like.Type: ApplicationFiled: November 11, 2021Publication date: November 16, 2023Applicants: KOREA MOUSE PHENOTYPING CENTER, NATIONAL CANCER CENTER, SEOUL NATIONAL UNIVERSITY R&DB FOUNDATIONInventors: Je Kyung Seong, Ho Lee, Seung Hyun Oh, Min Woo Kim, Yoon Jeon
-
Publication number: 20230364163Abstract: To provide a pharmaceutical composition capable of enhancing the effect of an immune checkpoint inhibitor against tumor or cancer in a subject. Provided is a pharmaceutical composition that comprises bacterial cells, a culture supernatant, a metabolite, and/or a bacterial cell extract of Ruminococcaceae enterobacterium, and is administered in combination with an immune checkpoint inhibitor.Type: ApplicationFiled: September 29, 2021Publication date: November 16, 2023Applicants: NATIONAL CANCER CENTER, RIKENInventors: Hiroyoshi Nishikawa, Shota Fukuoka, Yoshimi Benno, Yuko Shigeno
-
Patent number: 11813332Abstract: The present invention relates to a conjugate for photodynamic diagnosis or treatment in which a peptide binds with a photosensitizer via an intracellularly degradable linkage, and to a composition for photodynamic diagnosis or treatment including the same.Type: GrantFiled: July 4, 2017Date of Patent: November 14, 2023Assignee: NATIONAL CANCER CENTERInventors: Yong-Doo Choi, Ji-Su Kim
-
Publication number: 20230346835Abstract: An antibody specifically binding to BCMA (B-cell maturation antigen) or fragment thereof, including: a heavy chain variable region including a CDR1 region represented by the amino acid sequence of SEQ ID NO: 1, a CDR2 region represented by the amino acid sequence of SEQ ID NO: 2, and a CDR3 region represented by the amino acid sequence of SEQ ID NO: 3; and a light chain variable region including a CDR1 region represented by the amino acid sequence of SEQ ID NO: 4, a CDR2 region represented by the amino acid sequence of SEQ ID NO: 5, and a CDR3 region represented by the amino acid sequence of SEQ ID NO: 6.Type: ApplicationFiled: May 28, 2021Publication date: November 2, 2023Applicants: NATIONAL CANCER CENTER, PROTANBIO INC.Inventors: Sangjin LEE, Hyeonseok EOM, Eunjung PARK, Bumkyu CHOI, Soyoun RO, Seongwon HONG, Chungyong HAN, Jeyoel CHO, Hyejin SUNG, Siyoung CHOI
-
Publication number: 20230348587Abstract: An objective of the present invention is to provide an anti-TSPAN8/anti-CD3 bispecific antibody and an anti-TSPAN8 antibody usable in treatment or prevention in human. A human monoclonal antibody producing mouse was immunized with a peritoneal disseminated cancer cell isolated from a patient, to obtain an antibody 16B11 and an antibody 16B12 that selectively bind to a peritoneal disseminated cancer cell. These antibodies were anti-TSPAN8 antibodies that bind to the region from amino acid positions 126 to 155 of TSPAN8 and exhibited strong binding activity to TSPAN8 expressed in the peritoneal disseminated cancer cell. Further, an anti-TSPAN8(16B11)-anti-CD3 bispecific antibody produced based on the sequence of 16B11 exhibited a cytotoxic activity against the TSPAN8-expressing cancer cell in vitro, exerted an anti-tumor action on TSPAN8-expressing cancer cell-bearing mice in vivo, and extended the lifetime of peritoneal dissemination model mice.Type: ApplicationFiled: November 15, 2021Publication date: November 2, 2023Applicants: Astellas Pharma Inc., National Cancer CenterInventors: Yoshiyuki TENDA, Masatoshi YURI, Daisuke YAMAJUKU, Takeshi TSUTSUMI, Yuko KUSUZAKI, Hiroki SASAKI, Fumiko CHIWAKI, Masayuki KOMATSU
-
Publication number: 20230337893Abstract: Provided are an information processing device, a display method, and a program that allow to easily grasp during examination that a lesion is captured how long before from now which is detected by detection processing for an image captured by an endoscope. An information processing device (1) includes: an image acquisition unit (2) configured to sequentially acquire a current image captured by an endoscope; a lesion detection unit (3) configured to sequentially perform detection processing of a lesion site on the images sequentially acquired by the image acquisition unit (2); and a display control unit (4) configured to display, on a display device, a degree of lapse of time up to a current time from a capturing time of the image in which the lesion site is detected by the lesion detection unit (3).Type: ApplicationFiled: March 31, 2020Publication date: October 26, 2023Applicants: NEC CORPORATION, NATIONAL CANCER CENTERInventors: Ikuma TAKAHASHI, Tatsu KIMURA, Kimiyasu TAKOH, Kenichi KAMIJO, Shota OHTSUKA, Motoyasu OKUTSU, Masayoshi YAMADA, Ryuji HAMAMOTO, Yutaka SAITO
-
Patent number: 11786710Abstract: The present invention provides a skull implant-type automatic fluid drain device comprising: a body having a first port to be connected to a catheter, a second port provided opposite the first port, and a flow passage connecting the first port and the second port; a separation member for separating the flow passage into first and second sub-channels; a first valve fixed to the separation member and provided to allow the movement of a fluid that moves from the first port to the second port in the first sub-channel; and a second valve fixed to the separation member and provided to allow the movement of a fluid that moves from the second port to the first port in the second sub-channel, wherein each of the first valve and the second valve has an inflow end portion that is open and a discharge end portion provided in a closed state such that the same is selectively opened at an allowed opening pressure or higher; each of the first valve and the second valve is configured such that the inner flow sectional area deType: GrantFiled: April 24, 2018Date of Patent: October 17, 2023Assignees: National Cancer Center, Eulji University Industry Academy Cooperation FoundationInventors: Heon Yoo, Kwang Gi Kim, Young Tae Kim, Seung Hoon Lee
-
Patent number: 11788150Abstract: This invention provides a kit or a device for the detection of pancreatic cancer, comprising a nucleic acid(s) capable of specifically binding to a miRNA(s) in a sample from a subject, and a method for detecting pancreatic cancer, comprising measuring the miRNA(s) in vitro.Type: GrantFiled: December 7, 2020Date of Patent: October 17, 2023Assignees: Toray Industries, Inc., National Cancer CenterInventors: Junpei Kawauchi, Hitoshi Nobumasa, Satoko Kozono, Satoshi Kondou, Hiroko Sudo, Atsushi Ochiai, Motohiro Kojima
-
Patent number: 11761046Abstract: The present invention provides a kit or device for the detection of biliary tract cancer, and a method for detecting biliary tract cancer. The present invention relates to a kit or device for the detection of biliary tract cancer, comprising a nucleic acid capable of specifically binding to miRNA in a sample of a subject, and a method for detecting biliary tract cancer, comprising measuring the miRNA in vitro.Type: GrantFiled: September 8, 2022Date of Patent: September 19, 2023Assignees: TORAY INDUSTRIES, INC., NATIONAL CANCER CENTERInventors: Junpei Kawauchi, Hitoshi Nobumasa, Satoko Kozono, Satoshi Kondou, Hiroko Sudo, Atsushi Ochiai, Motohiro Kojima
-
Publication number: 20230288582Abstract: The disclosure relates to a device for detecting therapeutic radiation based on an optical disk with solar cells. The radiation detecting device may include at least one optical disk formed of a water-equivalent material, disposed perpendicular to a first direction in which the radiation is incident, and converting the radiation into visible light; a solar cell disposed on one side of the at least one optical disk, converting the visible light into an electrical signal; and a processing module for collecting and processing the electrical signal outputted from the solar cell.Type: ApplicationFiled: March 10, 2023Publication date: September 14, 2023Applicants: NATIONAL CANCER CENTER, SEOUL NATIONAL UNIVERSITY HOSPITALInventors: Dongho SHIN, Tae Hyun KIM, Tae-Ho KIM, Haksoo KIM, Dong-Seok SHIN, Se Byeong LEE, Youngkyung LIM, Jonghwi JEONG, Jaeman SON